Hiroshi Uchi - Concepedia

Author

Hiroshi Uchi

Also Known As

Fumitaka Ohno, H Uchi, H. Uchi, Hiroshi UCHI, Hiroshi Uchi, J Tyler, Kentaro Yamamura, Masutaka Furue, S. Yoshikawa, U. Hiroshi

390

Publications

Citations

H-Index

135

Concepts

All Affiliations

Kyushu University Kyushu University Hospital University of Tsukuba Shizuoka Cancer Center Kumamoto University

About

Hiroshi Uchi is an author at Kyushu University specializing in medicine, dermatology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	69	3K
2	Public Health	7	7	222
3	Allergy	4	4	156
4	Health Sciences	3	3	118
5	Natural Sciences	1	1	10

Hiroshi Uchi

130

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
An environmental contaminant, benzo(a)pyrene, induces oxidative stress-mediated interleukin-8 production in human keratinocytes via the aryl hydrocarbon receptor signaling pathway Gaku Tsuji, Masakazu Takahara, Hiroshi Uchi, Journal of Dermatological Science InflammationRespiratory ToxicologyMedicineAryl Hydrocarbon ReceptorToxicology	2011	205
Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer Hiroshi Uchi, Atsuyuki Igarashi, Kazunori Urabe, European Journal of Dermatology Regenerative MedicineDiabetic UlcerFibrosisRefractory Skin UlcerDiabetes	2009	170
Identification of Ketoconazole as an AhR-Nrf2 Activator in Cultured Human Keratinocytes: The Basis of Its Anti-Inflammatory Effect Gaku Tsuji, Masakazu Takahara, Hiroshi Uchi, Journal of Investigative Dermatology	2011	163
A proposal for a TNM staging system for extramammary Paget disease: Retrospective analysis of 301 patients with invasive primary tumors Kuniaki Ohara, Yasuhiro Fujisawa, Koji Yoshino, Journal of Dermatological Science Surgical OncologyTnm Staging SystemTumoral PathologyMedicineSurgical Pathology	2016	148
Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis Gaku Tsuji, Akiko Hashimoto‐Hachiya, Mari Kiyomatsu‐Oda, Cell Death and Disease	2017	135
Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs Takeshi Nakahara, Hiroshi Uchi, Alexander M. Lesokhin, Blood	2010	134
Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma Naoya Yamazaki, Yoshio Kiyohara, Hisashi Uhara, Cancer Science Cytokine BiomarkersImmunologyImmunoeditingImmunotherapeuticsImmunotherapy	2017	124
Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma Yasuhiro Fujisawa, Shusuke Yoshikawa, Akane Minagawa, Cancer Medicine	2019	106
Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study Taku Fujimura, Yota Sato, Kayo Tanita, Oncotarget	2018	88
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial PK Judge, Natalie Staplin, KJ Mayne, The Lancet Diabetes & Endocrinology	2023	88

Page 1